| Abdoulaye Diabaté | |
| Birth Place: | Burkina Faso |
| Workplaces: | National Institutes of Health |
| Alma Mater: | University of Montpellier II University of Ouagadougou |
| Thesis Title: | Le paludisme au Burkina Faso : étude de la transmission et répartition géographique de la résistance d'"Anopheles gambiae" SL aux pyréthrinoïdes |
| Thesis Url: | https://search.worldcat.org/en/title/1164575803 |
| Thesis Year: | 2003 |
Abdoulaye Diabaté is an African parasitologist, Professor and Head of the Medical Entomology and Parasitology Department at the Health Sciences Research Institute. His research considers the use of gene drive to eliminate malaria, and he leads Target Malaria Burkina Faso. He delivered the first genetically modified mosquitoes in Africa, marking a historic moment for science. He was awarded the 2023 Falling Walls Science Prize for Science and Innovation Management.
Diabaté grew up in a small village in Burkina Faso.[1] As a child he suffered from many episodes of malaria, and almost died when he was four years old. This experience was pivotal in his vocation to take on a scientific career and dedicate it to finding innovative solutions to fight malaria. He obtained a Doctorate of Animal Biology and Ecology degree at the University of Ouagadougou. In particular Professor Diabaté studied insecticide resistance. He earned his PhD in parasitology at the University of Montpellier II.[2] He was a postdoctoral researcher at the Laboratory of Malaria and Vector Research in the National Institutes of Health from 2005. It was the first time he had left Burkina Faso, and he joined a research group studying Anopheles gambiae. After completing his fellowship, he returned to Burkina Faso in 2009 and took up a position at the Research Institute in Health Sciences (Institut de Recherche en Sciences de la Santé) in Bobo-Dioulasso, Burkina Faso.[3]
His research has focused on population biology and the biology of mosquito males. In 2009 he was particularly interested in methods to interrupt mosquito mating and related approaches to vector-borne disease control. He returned to Burkina Faso in 2009, where he was awarded a Tropical Disease Research (TDR) World Health Organization grant. He partnered with Keele University and started studying swarms of Anopheles gambiae. He was awarded a Medical Research Council and Department for International Development African Research Leader Scheme fellowship, and expanded his research programme on medical entomology.
In 2013 he was awarded the Royal Society Pfizer Award for his work on the biology of Anopheles. He pioneered some of the most advanced work on using genetically modified mosquitoes to tackle malaria, and led the Target Malaria Burkina Faso/IRSS team through the first genetically modified mosquito release in Africa in 2019.[4] [5] [6] It was developed in the UK at Imperial College London, tested in the UK and Italy and imported to the insectary at the Institut de Recherche en Sciences de la Santé (IRSS) in Bobo-Dioulasso, Burkina Faso. He is currently studying it under contained use and hope to conduct an experimental field release in 2025.
Diabaté’s team genetically modified the fungi Metarhizium pingshaense to deliver insecticidal proteins into mosquito blood. This transgenic fungus is engineered to express an insect-specific spider neurotoxin (Ca++/K+ channel blocker).[7]